Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).
Factors for lower walking speed in persons with multiple sclerosis.
Notch Signaling and T-Helper Cells in EAE/MS.
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.
Glial influence on the blood brain barrier.
Using Functional Electrical Stimulation Mediated by Iterative Learning Control and Robotics to Improve Arm Movement for People With Multiple Sclerosis.
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
[Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of Β-interferon 1a (avonex).]
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Treatment of cognitive impairment in patients with multiple sclerosis.
[Affective and psychotic disorders in multiple sclerosis].
Multiple sclerosis: Brain volume loss strengthens disease measure.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
The effects of identification with a support group on the mental health of people with multiple sclerosis.
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.
Influence of Peripheral inflammation on the progression of Multiple Sclerosis: Evidence from the clinic and experimental animal models.
LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.
Epigenetics in NG2 glia cells.
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
Pages
« first
‹ previous
…
283
284
285
286
287
288
289
290
291
…
next ›
last »